Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | SWIB/MDM2 domain-containing protein | 0.043 | 0.4787 | 1 |
Loa Loa (eye worm) | brahma associated protein | 0.043 | 0.4787 | 0.4787 |
Echinococcus multilocularis | mitogen activated protein kinase 11 | 0.0731 | 1 | 1 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.043 | 0.4787 | 0.4787 |
Echinococcus granulosus | SWI:SNF matrix associated | 0.043 | 0.4787 | 0.4787 |
Schistosoma mansoni | hypothetical protein | 0.043 | 0.4787 | 1 |
Schistosoma mansoni | hypothetical protein | 0.043 | 0.4787 | 1 |
Leishmania major | mitogen-activated protein kinase 3, putative,map kinase 3, putative | 0.0731 | 1 | 1 |
Onchocerca volvulus | 0.043 | 0.4787 | 1 | |
Trypanosoma cruzi | mitogen-activated protein kinase 3, putative | 0.0731 | 1 | 1 |
Schistosoma mansoni | brg-1 associated factor | 0.043 | 0.4787 | 1 |
Echinococcus granulosus | mitogen activated protein kinase 11 | 0.0731 | 1 | 1 |
Toxoplasma gondii | DNA topoisomerase domain-containing protein | 0.043 | 0.4787 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.043 | 0.4787 | 0.5 |
Brugia malayi | SWIB/MDM2 domain containing protein | 0.043 | 0.4787 | 0.4787 |
Chlamydia trachomatis | SWIB complex protein | 0.043 | 0.4787 | 0.5 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.043 | 0.4787 | 1 |
Echinococcus granulosus | Upstream activation factor subunit UAF30 | 0.043 | 0.4787 | 0.4787 |
Schistosoma mansoni | hypothetical protein | 0.043 | 0.4787 | 1 |
Trypanosoma brucei | mitogen-activated protein kinase 3, putative | 0.0731 | 1 | 1 |
Echinococcus granulosus | mitogen activated protein kinase 14 | 0.0731 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.043 | 0.4787 | 0.5 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.043 | 0.4787 | 0.4787 |
Echinococcus multilocularis | Upstream activation factor subunit UAF30 | 0.043 | 0.4787 | 0.4787 |
Trypanosoma cruzi | mitogen-activated protein kinase 3, putative | 0.0731 | 1 | 1 |
Echinococcus multilocularis | mitogen activated protein kinase 14 | 0.0731 | 1 | 1 |
Chlamydia trachomatis | DNA topoisomerase I | 0.043 | 0.4787 | 0.5 |
Plasmodium vivax | SWIB/MDM2 domain-containing protein, putative | 0.043 | 0.4787 | 0.5 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.043 | 0.4787 | 1 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.043 | 0.4787 | 0.4787 |
Brugia malayi | brahma associated protein 60 kDa | 0.043 | 0.4787 | 0.4787 |
Echinococcus multilocularis | mitogen activated protein kinase 11 | 0.0731 | 1 | 1 |
Loa Loa (eye worm) | SWIB/MDM2 domain-containing protein | 0.043 | 0.4787 | 0.4787 |
Echinococcus multilocularis | mitogen activated protein kinase 14 | 0.0731 | 1 | 1 |
Loa Loa (eye worm) | CMGC/MAPK/P38 protein kinase | 0.0731 | 1 | 1 |
Brugia malayi | brahma associated protein 60 kDa | 0.043 | 0.4787 | 0.4787 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.